Technical Appendix: Cost-effectiveness of Vitamin Therapy for Age-Related Macular Degeneration

Ophthalmology

Volumn 114, Issue 7, 2007, Pages

  Rein, David B ^a   Saaddine, Jinan B ^b   Wittenborn, John S ^a   Wirth, Kathleen ^a   Hoerger, Thomas J ^a   Narayan, K M Venkat ^b   Clemons, Traci ^c   Sorensen, Stephen W ^b  

^a RTI INTERNATIONAL   (United States)

^b NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

^c EMMES CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; BENZOPORPHYRIN DERIVATIVE; BETA CAROTENE; ZINC;

AGE DISTRIBUTION; ARTICLE; CONTRAST SENSITIVITY; COST EFFECTIVENESS ANALYSIS; DRUG MEGADOSE; EYE FUNDUS; FLUORESCENCE ANGIOGRAPHY; HEALTH CARE COST; HUMAN; LASER COAGULATION; MEDICARE; NURSING HOME; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; REIMBURSEMENT; RETINA IMAGE; RETINA MACULA AGE RELATED DEGENERATION; SIMULATION; SUBRETINAL NEOVASCULARIZATION; TREATMENT OUTCOME; VISION; VISUAL ACUITY; VISUAL FIELD; VISUAL IMPAIRMENT; VITAMIN SUPPLEMENTATION;

COST-BENEFIT ANALYSIS; DRUG COSTS; HUMANS; MACULAR DEGENERATION; VITAMINS;

EID: 34347204489     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ophtha.2006.10.064     Document Type: Article

References (8)

1. Rein D.B., Saaddine J.B., Wittenborn J.S., et al. Cost-effectiveness of vitamin therapy for age-related macular degeneration. Ophthalmology 114 (2007) 1319-1326
2. Brown M.M., Brown G.C., Sharma S., et al. Health care economic analyses and value-based medicine. Surv Ophthalmol 48 (2003) 204-223
3. National Research Council. Visual Impairments: Determining Eligibility for Social Security Benefits (2002), National Academy Press, Washington
4. National Ambulatory Medical Care Survey. National Center for Health Statistics. Available at: ftp://ftp.cdc.gov/pub/Health_Statistics/NCHS/Datasets/NAMCS. Accessed March 1, 2006.
5. Burt C. Using Past Visit History to Enhance Analysis of National Ambulatory Medical Care Survey (NAMCS) Data (2004), National Center for Health Statistics, Hyattsville, MD
6. Eye Diseases Prevalence Research Group. Prevalence of age-related macular degeneration in the United States. Arch Ophthalmol 122 (2004) 564-572
7. Eye Diseases Prevalence Research Group. Causes and prevalence of visual impairment among adults in the United States. Arch Ophthalmol 122 (2004) 477-485
8. van Leeuwen R., Klaver C.C.W., Vingerling J.R., et al. The risk and natural course of age-related maculopathy. Follow-up at 6 1/2 years in the Rotterdam Study. Arch Ophthalmol 121 (2003) 519-526